Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Amplia gets nod for new cancer drug trial ahead of US push

Amplia Therapeutics has received ethics approval for its ACCENT-Mini pancreatic cancer trial, paving the way to test daily doses of its narmafotinib drug alongside chemotherapy.

Amplia gets nod for new cancer drug trial ahead of US push

We haven't written up this one. The Sydney Morning Herald has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Every outlet that reported this, and when →

Read the original at smh.com.au →

More in Health & Medicine

More from Thursday 19 November →